Trials / Unknown
UnknownNCT04951882
Application of hUC-MSCs in Treating Acute Lung Injury: a Single Center Prospective Clinical Research
Transplatation of Human Umbilcal Cord Derived Mesenchyamal Stem Cells in Acute Lung Injury: a Single Center Prospective Clinical Research
- Status
- Unknown
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The patients suffered from acute lung ininjury (200\<PaO2/FiO2 ≤ 300) will be divided into two groups: MSCs-treated group: patients are treated by intravenous injection of hUC-MSCs suspention ; control group: patients were treated with vehicle(Albumin) . The standard Therapies of acute lung injury were the same in both groups. In the following-up days, all the patients were monitored by the same items to evaluate the therapeutic effects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | human derived umbilical cord derived mesenchymal stem cells | intravenous transplantation of human derived umbilical cord derived mesenchymal stem cells |
Timeline
- Start date
- 2021-06-09
- Primary completion
- 2022-12-31
- Completion
- 2022-12-31
- First posted
- 2021-07-07
- Last updated
- 2021-07-07
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04951882. Inclusion in this directory is not an endorsement.